by Dr Andrew Clements | Jun 1, 2018 | Briefings, UK
Introduction SPCs are national rights provided for by EU regulations. The European Commission published a proposal for a new Regulation on 28 May 2018 to amend Regulation (EC) No469/2009 concerning the SPC for medicinal products. Further details of the proposal can be...
by Alex Bajjon | Jun 1, 2018 | Briefings, EPO
In this case, an opposition was filed against European Patent No. 2177045 (in the name of Freebit AS) by the patent attorney firm, Santarelli SA. At first instance, the Opposition Division held that the claims of the patent were new, inventive and sufficient and...
by Alex Bajjon | Apr 1, 2018 | Briefings, Trademarks
Introduction Trade marks may be protected by registration at national or regional (such as at the EU) trade mark offices. Registered trade marks provide the holder the right to exclude others from using the same or a similar trade marks for the same or similar...
by Carolyn Haywood | Mar 1, 2018 | Briefings, UK
Reassuringly, the draft Withdrawal Agreement explicitly addresses Intellectual Property and pleasingly confirms that the European Union is prepared to agree to continuous protection in the UK, by way of a corresponding UK right, for owners of an EU trade mark or a...
by David Eyre | Mar 1, 2018 | Briefings, US & International
Extending the patent term for such high value patented products can be particularly significant for rights holders even when the additional term is mere days. A supplementary protection certificate is intended to partially compensate a patent holder for the patent...
by Sean Hughes | Mar 1, 2018 | Briefings, US & International
Europe The Enlarged Board of Appeal in G 02/08 clarified that second medical use claims to new and inventive dosage regimes are patentable, even where the substance or composition, and the disease to be treated, are the same as in the prior art. Nevertheless, the...
Recent Comments